多克萨普拉姆的作用及其与K2P通道的潜在相互作用在实验模型制剂中的作用
Elizabeth R Elliott1, Kaitlyn E Brock1, Rachael M Vacassenno1
1Department of Biology, University of Kentucky, Lexington, KY, 40506-0225, USA.
概括
双孔域 (K2P) 通道维持细胞的休息潜力. 德克萨普拉姆是一个多克萨普拉姆.
科学领域:
- 神经科学是一个神经科学.
- 离子通道生理学 离子通道生理学
- 比较生理学比较生理学
背景情况:
- 双孔域 (K2P) 通道对于维持细胞静止膜潜能至关重要.
- 这些通道通常是开放的,但对pH等环境因素敏感.
- 有限的信息存在于无脊椎动物的K2P通道功能.
研究的目的:
- 研究K2P通道在无脊椎动物中的生理作用.
- 为了检查多克萨普拉姆,一个已知的K2P通道阻塞剂,对神经和肌肉组织的影响.
- 为了比较Drosophila幼虫和鱼中的K2P通道活性.
主要方法:
- 对幼虫Drosophila和鱼进行了电生理学记录.
- 评估了多克萨普拉姆不同度的影响.
- 测量包括肌肉纤维脱极化,突触传输和动作潜能生成.
主要成果:
- 多克萨普拉姆导致了多索菲拉肌肉的剂量依赖脱极化,并增加了突触传输.
- 在鱼中,多克萨普拉姆阻断了运动神经元中的动作潜能产生,但对肌肉休息潜能的影响很小.
- 这些差异性效应表明Drosophila和鱼组织中存在不同的K2P通道亚型.
结论:
- 龙和龙中的神经和肌肉组织可能表达不同的K2P通道亚型.
- 需要进一步的研究来确定这些无脊椎动物模型中的特定K2P通道.
- 了解无脊椎动物的K2P通道多样性可以促进神经生物学和生理学研究.
相关概念视频
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
972
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
972
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
823
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
823
01:20Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
01:19Depolarizing Blockers: Pharmocokinetics
319
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
319